CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 10-K Report Annual Report
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 79,925 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 7,399 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 10,647 shares (to pay taxes)
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 15,083 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 9,752 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 7,514 shares (to pay taxes)
- 4 Planned sale EVP R&D, Chief Medical Officer sold 100,918 shares at $32.05 ($3,234,382)
- 144 Insider Sale of Securities
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Agreement ended
- 4 Planned sale EVP R&D, Chief Medical Officer sold 61,151 shares at $32.07 ($1,961,406)
- 4 Planned sale Director sold 2,691 shares at $31.85 ($85,708)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,221 shares at $31.50 ($290,462)
- 144 Insider Sale of Securities
Page 11 of 97 · 1,927 filings